The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis
NCT04478591
·
clinicaltrials.gov ↗
COMPLETED
Status
117
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
OTHER:
Questionnaires
Sponsor
Amsterdam UMC, location VUmc